Track topics on Twitter Track topics that are important to you
They currently have an overweight rating on the specialty pharmaceutical company's stock. A number of other equities analysts have also weighed in on the company.
Original Article: Impax Laboratories, Inc. (IPXL) Price Target Raised to $35.00NEXT ARTICLE
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...